Literature DB >> 21134501

Immediate placement of intrauterine devices after first and second trimester pregnancy termination.

Michelle C Fox1, Julia Oat-Judge, Kathryn Severson, Roxanne M Jamshidi, Rameet H Singh, Raegan McDonald-Mosley, Anne E Burke.   

Abstract

BACKGROUND: We reviewed our experience with intrauterine device (IUD) placement after surgical abortion up to 20 weeks' gestation. STUDY
DESIGN: Women presenting for elective abortion between January 2004 and March 2009 who requested an IUD were included in this retrospective review.
RESULTS: Of 308 women requesting postabortion IUD placement, 221 (72%) planned insertion at the time of abortion (immediate group) and 87 (28%) planned insertion at their postoperative visit (interval group). IUDs were placed in 96% of the immediate group and in 23% of the interval group (212/221 vs. 20/87; p<.0001). Failure to return for placement was the most common reason for noninsertion in the interval group (60/87=69%). Follow-up information was obtained for 56% of patients and was documented a median of 137 days postabortion (range 3-1594 days). There was no difference in complication rates between groups. Expulsion rates were 3% and 0% in the immediate and interval groups, respectively (6/212 vs. 0/20; p=.4). Considering only those with documented follow-up after immediate insertion (119), there was a nonsignificant trend towards increased expulsion with placement after second vs. first trimester abortion (4/54=7% vs. 2/65=2%; p=.3). When analyzing the 172 subjects with documented follow-up, those planning immediate insertion were more likely to have an IUD in situ at the last contact than those planning later insertion (84/124=68% vs. 20/48=42%; p=.002).
CONCLUSION: Immediate postabortion IUD insertion is safe and effective. Given the low rate of return for interval insertion, immediate placement may be preferable.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 21134501     DOI: 10.1016/j.contraception.2010.06.018

Source DB:  PubMed          Journal:  Contraception        ISSN: 0010-7824            Impact factor:   3.375


  7 in total

1.  Immediate post-abortion insertion of intrauterine contraceptives (IUC) in a diverse urban population.

Authors:  DeShawn Taylor; Shannon Connolly; Sue Ann Ingles; Carey Watson; Penina Segall-Gutierrez
Journal:  J Immigr Minor Health       Date:  2014-06

2.  Immediate postabortion intrauterine device insertion: continuation and satisfaction.

Authors:  Colleen McNicholas; Taylor Hotchkiss; Tessa Madden; Qiuhong Zhao; Jenifer Allsworth; Jeffrey F Peipert
Journal:  Womens Health Issues       Date:  2012 Jul-Aug

3.  Postabortion Contraceptive Use and Continuation When Long-Acting Reversible Contraception Is Free.

Authors:  Vinita Goyal; Caitlin Canfield; Abigail R A Aiken; Amna Dermish; Joseph E Potter
Journal:  Obstet Gynecol       Date:  2017-04       Impact factor: 7.661

4.  Rationale and enrollment results for a partially randomized patient preference trial to compare continuation rates of short-acting and long-acting reversible contraception.

Authors:  David Hubacher; Hannah Spector; Charles Monteith; Pai-Lien Chen; Catherine Hart
Journal:  Contraception       Date:  2014-11-15       Impact factor: 3.375

5.  Visibility of Strings After Postplacental Intracesarean Insertion of CuT380A and Cu375 Intrauterine Contraceptive Device: A Randomized Comparative Study.

Authors:  Kavita Agarwal; Rupali Dewan; Pratima Mittal; Abha Aggarwal
Journal:  J Obstet Gynaecol India       Date:  2017-01-30

6.  Does the type of abortion provider influence contraceptive uptake after abortion? An analysis of longitudinal data from 64 health facilities in Ghana.

Authors:  Lauren Maxwell; Gertrude Voetagbe; Mary Paul; Alice Mark
Journal:  BMC Public Health       Date:  2015-06-24       Impact factor: 3.295

7.  Nurse versus physician-provision of early medical abortion in Mexico: a randomized controlled non-inferiority trial.

Authors:  Claudia Diaz Olavarrieta; Bela Ganatra; Annik Sorhaindo; Tahilin S Karver; Armando Seuc; Aremis Villalobos; Sandra G García; Martha Pérez; Manuel Bousieguez; Patricio Sanhueza
Journal:  Bull World Health Organ       Date:  2015-02-19       Impact factor: 9.408

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.